Vaginitis/cervicitis: Diagnosis and treatment options in a limited resource environment

Women's Health Issues

Volumn 6, Issue 6, 1996, Pages 342-348

  Landers, Daniel V ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; FLUCONAZOLE; METRONIDAZOLE;

ARMY; CHLAMYDIASIS; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; RESOURCE ALLOCATION; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; UNITED STATES; UTERINE CERVICITIS; VAGINA CANDIDIASIS; VAGINITIS;

BACTERIAL INFECTIONS; CANDIDIASIS, VULVOVAGINAL; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; MALE; MILITARY PERSONNEL; RISK FACTORS; TRICHOMONAS VAGINITIS; UNITED STATES; UTERINE CERVICITIS; VAGINITIS; WOMEN'S HEALTH;

EID: 0030294451     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1049-3867(96)00061-8     Document Type: Conference Paper

References (31)

1. 1. U.S. Department of Health and Human Services. Summary of notifiable diseases, United States, 1994. MMWR 1994;43:1-68.
2. 2. Sweet RL, Gibbs RS. Sexually transmitted diseases. In: Infectious diseases of the female genital tract, 3rd ed. Baltimore: Williams & Wilkins, 1995:133-81.
3. 3. Malone JD, Hyams KC, Hawkins RE, et al. Risk factors for sexually-transmitted diseases among deployed U.S. military personnel. Sex Trans Dis 1993;20: 294-8.
4. 4. Committee on Defense Women's Health Research, Institute of Medicine: Recommendations for research on the health of military women. Washington (DC): National Academy Press, 1995:6-18.
5. 5. Catterson ML, Zadoo V. Prevalence of asymptomatic chlamydial cervical infection in active duty Army females. Mil Med 1993;158:618-9.
6. 6. Holly EA, Cress RD, Ahn DK, et al. Characteristics of women by smoking status in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 1992;1:491-7.
7. 7. Scholes D, Daling JR, Stergachis AS. Current cigarette smoking and the risk of acute pelvic inflammatory disease. Am J Public Health 1992;82:1352-5.
8. 8. Shafer MA, Pessione F, Scieux C et al. Chlamydia trachomatis: risk factors in women in the Parisian region: importance of smoking and cervical ectropion. J Gynecol Obstet Biol Reprod 1993;22:163-8.
9. 9. Laga A, Manoka A, Kivuvu M, et al. Non-ulcerative STDs as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102.
10. 10. Plummer FA, Simonsen JN, Cameron DW et al. Co-factors in male-female transmission of HIV-1. J Infect Dis 1991;163:233-9.
11. 11. Cates W Jr. Epidemiology and control of sexually transmitted diseases: strategic evolution. Infect Dis Clin North Am 1987;1:1-23.
12. 12. Sweet RL, Gibbs RS. Infectious vulvovaginitis. In: Infectious diseases of the female genital tract, 3rd ed. Baltimore: Williams & Wilkins, 1995:341-62.
13. 13. Washington AE, Johnson RE, Sanders LL et al. Incidence of Chlamydia trachomatis infections in the United States: using reported Neisseria gonorrhoeae as a surrogate. In: Oriel D, Ridgeway G, Schachter J, et al., editors. Chlamydial infections. Cambridge: Cambridge University Press, 1986:487-90.
14. 14. Cates W Jr, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991;164:1771-81.
15. 15. Sweet RL, Gibbs RS. Infectious vulvovaginitis. In: Infectious diseases of the female genital tract. 3rd ed. Baltimore: Williams and Wilkins, 1995:341-62.
16. 16. Centers for Disease Control. 1993 Sexually transmitted disease guidelines. MMWR 1993;42:1-102.
17. 17. Oriel JD, et al. Genital yeast infections. BMJ 1972;4:761.
18. 19. Hillier S, Holmes KK. Bacterial vaginosis. In: Holmes KK, Mardh P-A, Sparling PF, Weisner PJ (eds). Sexually transmitted diseases, 2nd ed. New York: McGraw-Hill Inc., 1990:547-59.
19. 20. Masson PL, Heremans JF, Schonne E, et al. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 1969;130:643-58.
20. 21. Leffell MS, Spitznagel JK. Association of lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes. Infect Immun 1972;6:761-5.
21. 22. Hillier SL. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169:455-9.
22. 23. Sonnex C. The amine test: a simple, rapid inexpensive method for diagnosing bacterial vaginosis. Br J Obstet Gynecol 1995;102:160-1.
23. 24. Wiesenfeld HC, Heine RP, Rideout A, Macio I, DiBiasi F, Sweet RL. The vaginal introitus: a novel site for Chlamydia trachomatis testing in women. Am J Obstet Gynecol (in press).
24. 25. Wiesenfeld HC, Heine RP, Rideout A, Macio I, DiBiasi F, Repp A, Sweet RL. The distal vagina is a novel site for gonorrhea testing. Proceedings of 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1995, San Francisco, Abstract K86.
25. 26. Heine RP, Wiesenfeld HC, DiBiasi F, Witkin S, Rideout A, Macio I, Sweet RL. In: The vaginal introitus: a non-invasive testing site for Trichomonas vaginalis. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1995, San Francisco, Abstract K87.
26. 27. Martin DH, Mroczkowski TE, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydia urethritis and cervicitis. N Engl J Med 1992;327:921-5.
27. 28. Handsfield HH, Dalu ZA, Martin DH, et al. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Sex Trans Dis 1994;21:108-11.
28. 29. Steingrimsson O, Olafsson JH, Thorarinsson H, et al. Azithromycin in the treatment of uncomplicated sexually transmitted disease. J Antimicrob Chemother 1990;25 Suppl A 109-14.
29. 30. Waugh M. Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhea in men and women. J Antimicrob Chemother 1993;31(Suppl E):193-8.
30. 31. de los Reyes C, Edelman DE, De Bruin MF. Clinical experience with single dose fluconazole in vaginal candidiasis: a review of the worldwide database. Int J Gynecol Obstet 1992;37(Suppl):9-15.
31. 32. Hager WD. Trichomonas vaginalis infection. In: Pastorek, JG, editor. Obstetric and Gynecologic Infectious Disease. New York: Raven Press, 1994:537-44.